Keros Therapeutics, Inc. (NASDAQ:KROS) Poised For Near-Term Pullback Amid Strong Trend Dynamics
![]() |
Keros shows financial strength from a large cash position and an under-valued WMDST valuation, but technicals point to a near-term weakening that could pressure price into consolidation. Fundamental metrics support capital flexibility while recent corporate actions concentrate capital return and strategic focus. |









